STOCK TITAN

If You Invested in Neon Bloom (NBCO)

Healthcare · Biotechnology · OTC Link
Looking for the live price? See the NBCO quote & overview
$1,000 invested 1 Year Ago
$602
-39.8% total -40.5% CAGR
Bought on Jul 7, 2025 at $0.01
$1,000 invested 5 Years Ago
$14
-98.6% total -57.8% CAGR
Bought on Jul 6, 2021 at $0.44

What $1,000 or $10,000 in NBCO Would Be Worth Today

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Jul 7, 2015
$1,000 $602 -40% $14 -99% $30 -97% $98 -90%
$10,000 $6,020 -40% $136 -99% $295 -97% $983 -90%

Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for NBCO

$1,000 Investment Over Time

NBCO vs S&P 500

Year-by-Year Returns

NBCO annual performance
Year Start Price End Price Annual Return Cumulative
2017 $0.33 $0.04 -87.9% -87.9%
2018 $0.04 $1.55 +3775.0% +369.7%
2019 $1.55 $1.60 +3.2% +384.8%
2020 $1.65 $0.77 -53.3% +133.3%
2021 $0.77 $0.22 -71.4% -33.3%
2022 $0.22 $0.11 -48.9% -65.9%
2023 $0.11 $0.01 -92.5% -97.5%
2024 $0.01 $0.02 +218.2% -93.6%
2025 $0.03 $0.01 -74.9% -98.0%
2026 $0.01 $0.01 -10.6% -98.2%

About Neon Bloom

Healthcare · OTC Link

Neon Bloom, Inc. (OTC PINK: NBCO) is described in its public communications as a diversified enterprise group and holding company with activities spanning life-science technologies, technologically improved financial services, and other emerging businesses with high growth potential and cross-industry segment synergies. Over time, the company has emphasized investments in healthcare, financial services, technology, and related sectors, and has used acquisitions as a primary tool for expanding its business footprint.

Business Focus and Strategy

According to multiple company announcements, Neon Bloom positions itself as a holding company that seeks to grow through acquisitions and organic expansion in sectors it views as synergistic. Its disclosures state that it intends to use a mix of common stock, non-convertible promissory performance-based notes, and available cash to complete additional acquisitions. The company has highlighted a strategy of building a portfolio of businesses that can benefit from shared technology, financial services capabilities, and sector overlap.

In earlier periods, Neon Bloom’s historical focus was in the health and wellness space through its subsidiary Bazelet Health Systems Inc. Later communications describe a shift in primary focus toward the financial services industry, particularly the financial transaction processing sector, while continuing to reference life-science technologies and other emerging businesses.

Shift Toward Financial Services and Fintech

Recent press releases state that Neon Bloom has shifted its primary focus to the financial services sector, with an emphasis on the financial transaction processing segment. The company specifies that this focus excludes central bank-related transactions and includes areas such as reserve and liquidity, check, or other financial instrument clearinghouse services. Neon Bloom describes this as part of a broader move into digital financial technology that supports e-commerce and electronic payments.

A central element of this shift is the acquisition of Advanced Executive Sales (AES). Neon Bloom reports that it completed the acquisition of AES, converting it into a wholly owned subsidiary expected to operate as Advanced Executive Sales Inc. AES is characterized in company communications as a financial services business that provides business development and software solutions, specializing in electronic payment and card processing for various types of businesses.

Advanced Executive Sales (AES) Subsidiary

Through AES, Neon Bloom describes itself as active in e-commerce and point-of-sale transaction solutions. Company releases state that AES enables secure interactions between merchants and customers across a range of industries using its payment processing platform. AES is repeatedly described as a rapidly growing provider of e-commerce and point-of-sale transaction solutions, and as a provider of secure transaction software solutions.

Neon Bloom’s announcements further note that AES is a certified partner with entities such as YNLO Ultratech, Payshield, and WinGen (or Genwin) LLC, and that AES provides software-based support to over 100, and in some communications over 130, internet-based or e-commerce businesses under contract. The company also states that AES plans to expand into additional verticals and to acquire other financial services or financial technology firms with payment processing technology that complements AES’s existing capabilities.

AI-Driven Payment Processing and Technology

In more recent updates, Neon Bloom reports the implementation of an AI-driven backend software package across its payment processing platforms operated by AES. The company states that these platforms are now using multi-factor authentication and advanced artificial intelligence technology with the aim of reducing fraud, increasing capacity, and managing vendor redundancy and charge-backs. According to Neon Bloom, these changes are intended to support expansion of its customer base and entry into additional areas of the fintech industry.

The company also references business relationships with software development and business development partners, including Genwin LLC and Elevated International. These relationships are described as focused on back-end development software, transactional and software solutions in e-commerce, enterprise, and retail environments, and third-party business development intended to increase transactional and yearly revenue.

Life-Science and Bazelet Background

Neon Bloom’s earlier communications, and some later ones that describe the company more broadly, highlight its involvement in life-science technologies through its subsidiary Bazelet Health Systems Inc. Bazelet is described as the licensed U.S. plant patent, trademark, and manufacturer of PAN2020, a patented cannabis sativa plant with 0.00% THC and high Cannabigerol (CBG). Bazelet developed a proprietary ingredient called PECSA (Plant-based EndoCannabinoid System Activator), intended for use as a plant-based ingredient in food, drug, cosmetic, and related products that comply with the U.S. Food, Drug and Cosmetic Act.

Company materials state that Bazelet has worked on vertically integrated supply chains for its PECSA ingredient and has pursued initiatives such as PECSA Organic for the organic food and beverage industry, as well as programs to supply federally legal cannabis genetics to DEA-registered research entities for scientific research. Neon Bloom has also described itself at times as doing business as Bazelet Health Systems, Inc. and as a holding company with investments in healthcare and related sectors.

Later announcements, however, report that Neon Bloom divested Bazelet Health Systems Inc. as part of a shift away from the HealthTech sector and toward financial services following the acquisition of AES. These communications frame the divestment and acquisition together as a move away from cannabis-related controversy and toward digital financial technology and e-commerce-related payment processing.

Corporate Structure and Acquisition Approach

Across multiple releases, Neon Bloom describes itself as a holding company that seeks to maintain and acquire subsidiaries in healthcare, financial services, technology, and other emerging markets. It reports that it has used stock-for-ownership transactions to acquire subsidiaries such as Bazelet and AES. The company’s stated intention is to pursue additional acquisitions using shares of its common stock, non-convertible promissory performance-based notes, and cash as available.

Neon Bloom has also highlighted internal restructuring steps and changes in its leadership and board composition in connection with its strategic shift, though specific executive names and roles are not essential to understanding the company’s overall business model. The company has indicated that it aims to operate as a holding company with multiple subsidiaries contributing to revenue and net asset value.

Trading Venue and Sector Classification

In its public announcements, Neon Bloom identifies its shares as trading on the OTC PINK marketplace under the ticker symbol NBCO. While external classifications may place the company within healthcare or biotechnology based on its historical association with Bazelet and cannabis-related intellectual property, Neon Bloom’s own more recent descriptions emphasize its role in financial services, financial transaction processing, and fintech-related activities, alongside references to life-science technologies and other emerging businesses.

Business Model Overview

Based on the company’s disclosures, Neon Bloom’s business model centers on:

  • Operating as a holding company for subsidiaries in healthcare, financial services, technology, and other emerging sectors.
  • Focusing its primary efforts on the financial transaction processing segment of the financial services industry, excluding central bank-related transactions.
  • Owning and developing AES as a provider of e-commerce and point-of-sale transaction solutions and secure transaction software solutions for various industries.
  • Pursuing AI-driven enhancements to its payment processing platforms to address fraud, capacity, and operational efficiency.
  • Historically, owning Bazelet Health Systems Inc., which developed cannabis-based ingredients and intellectual property, and later divesting that subsidiary as part of a strategic shift toward financial services.
  • Seeking to grow revenue and net asset value through a combination of organic growth at its subsidiaries and additional acquisitions financed through equity and other instruments.

Position Within Its Markets

Neon Bloom’s communications describe its activities in e-commerce payment processing, point-of-sale transaction solutions, and secure transaction software through AES, and in life-science technologies and cannabis-derived ingredients through Bazelet prior to divestment. The company presents these activities as part of a broader participation in digital financial technology and emerging life-science applications, but does not provide detailed comparative market share or ranking data in the materials provided.

FAQs

Market Cap
$0.0B
Current Price
$0.01
View full NBCO overview

Frequently Asked Questions

Neon Bloom investment returns

How much would $1,000 invested in Neon Bloom be worth today?

If you invested $1,000 in Neon Bloom (NBCO) 10 years ago on 2016-07-06, your investment would be worth $30 today, representing a -97.1% total return, growing at a compounded rate of -29.7% per year (CAGR).

Has Neon Bloom outperformed the S&P 500?

Over the past 10 years, NBCO returned -97.1% compared to +255.2% for the S&P 500, underperforming the benchmark by 352.3 percentage points.

What is Neon Bloom's average annual return?

The compound annual growth rate (CAGR) of NBCO over the past 10 years is -29.7%, growing at a compounded rate each year. Individual years vary significantly — NBCO's best recent year was 2018 (+3775.0%) and worst was 2023 (-92.5%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.